SCHEMBL4929575

SCHEMBL4929575

Cc1cc(NC(=O)CC(=O)O)cc(C)c1OCc1cc(NCC2CC2)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
ALDH1A1 P00352 3/20 0.39
LIPC P11150 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
CRHR1 P34998 4/20 0.37
THRA P10827 2/20 0.36
THRB P10828 2/20 0.36
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
NR2E1 Q9Y466 1/20 0.35
ACP1 P24666 1/20 0.34
TACR1 P25103 1/20 0.34
TRPA1 O75762 1/20 0.34
CYP1A2 P05177 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717789 0.92 THRA (0.40) LMNAALDH1A1CRHR1THRATHRB
SCHEMBL4931718 0.89 THRA (0.42) LMNAALDH1A1LIPCLIPGCRHR1
SCHEMBL4926964 0.87 ALDH1A1 (0.39) ALDH1A1THRATHRBCNR1CNR2
SCHEMBL4923724 0.87 LMNA (0.43) LMNAALDH1A1THRATHRBNR2E1
SCHEMBL4929668 0.86 TRPA1 (0.48) LMNAALDH1A1THRATHRBNR2E1
SCHEMBL4932441 0.85 THRB (0.41) ALDH1A1CRHR1THRATHRB
SCHEMBL4931227 0.85 LMNA (0.45) LMNAALDH1A1THRATHRBNR2E1
SCHEMBL5109577 0.85 LMNA (0.45) LMNAALDH1A1THRATHRBNR2E1
SCHEMBL5104500 0.85 ALDH1A1 (0.52) LMNAALDH1A1THRATHRBNR2E1
SCHEMBL4929174 0.85 LMNA (0.40) LMNAALDH1A1THRATHRBNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA LMNA 3893/4885ALDH1A1 1818/4885LIPC 2519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.